SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Merck
Merck
Page 3 of 9
Health
Merck says the U.S. will buy 1.4 million doses of its COVID-19 antiviral pill
By
John Lauerman
and
Bloomberg
November 9, 2021
Health
Pfizer says its COVID pill cuts rates of death and hospitalization by 89%, sending shares skyward
By
David Meyer
November 5, 2021
Health
Merck’s new COVID-19 antiviral pill gets its first national approval—from the U.K.
By
Frank Connelly
and
Bloomberg
November 4, 2021
Health
Merck says poorer countries can produce its new COVID pill without paying royalties
By
David Meyer
October 27, 2021
Health
Rich countries’ rush to buy Merck antiviral pill risks leaving poor countries behind in COVID fight—again
By
James Paton
and
Bloomberg
October 12, 2021
Health
Merck asks FDA to authorize its breakthrough COVID antiviral pill
By
Matthew Perrone
and
The Associated Press
October 11, 2021
Health
Merck’s breakthrough COVID pill faces a risk: the virus could outsmart it
By
Thomas Mulier
,
Riley Griffin
and
Bloomberg
October 8, 2021
Health
Everything to know about Merck’s COVID antiviral pill
By
Emily Mullin
October 5, 2021
Health
Shares of vaccine makers slump as Merck unveils data from its ‘game-changer’ COVID pill
By
Abhishek Vishnoi
and
Bloomberg
October 4, 2021
Health
Merck says its experimental COVID-19 pill reduces hospitalizations and deaths by half
By
Matthew Perrone
and
The Associated Press
October 1, 2021
Health
The psychology behind why people will take horse paste, but not COVID vaccines
By
Sy Mukherjee
September 2, 2021
Health
Joe Rogan’s highly questionable ivermectin COVID-19 ‘cure’ may be lethal. It’s also catching on around the world
By
Sophie Mellor
September 2, 2021
Health
Booster shots and a big jump in market value: 3 takeaways from Moderna’s Q2 earnings
By
Sy Mukherjee
August 5, 2021
Tech
IBM, Merck and OneTen launch network to recruit and promote Black workers over the next decade
By
Jeff Green
and
Bloomberg
June 29, 2021
Health
Merck takes huge hit for its abandoned COVID-19 drug efforts
By
Riley Griffin
and
Bloomberg
May 6, 2021
Most Popular
Economy
Markets sold off after Powell said six words investors don’t want to hear: ‘Equity prices are fairly highly valued’
By
Jim Edwards
AI
Cathie Wood says the AI race has already shrunk to the 'Big 4' key players, and it could soon drop to 2
By
Marco Quiroz-Gutierrez
Economy
Millions of Americans brace for shock as Obamacare bills could soar by 75% in 2026
By
Ashley Lutz